ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,918.25
0.00%
Dow Jones
42,635.20
0.00%
US Dollar vs MXN
20.46314
0.22%
Brent Oil
76.465
0.63%
Bitcoin
92,768.95
-2.40%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Abivax SA (ABVX)

  7. Abivax SA (ABVX) Noticias

ABVX

Abivax (ABVX)

Abivax SA
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ABVX
FechaHoraFuenteTítuloSímboloCompañía
23/12/202416:14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ABVXAbivax SA
23/12/202415:05GlobeNewswire Inc.Abivax Announces a Change to the Composition of its Board of DirectorsNASDAQ:ABVXAbivax SA
26/11/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ABVXAbivax SA
19/11/202415:30GlobeNewswire Inc.Abivax Establishes an At-the-Market (ATM) Program on NasdaqNASDAQ:ABVXAbivax SA
19/11/202415:02Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:ABVXAbivax SA
14/11/202415:01GlobeNewswire Inc.Abivax presents third quarter 2024 key financial informationNASDAQ:ABVXAbivax SA
13/11/202415:01GlobeNewswire Inc.Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to AbivaxNASDAQ:ABVXAbivax SA
07/10/202415:01GlobeNewswire Inc.Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene RegulationNASDAQ:ABVXAbivax SA
03/10/202415:01GlobeNewswire Inc.Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s DiseaseNASDAQ:ABVXAbivax SA
03/10/202401:31GlobeNewswire Inc.Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label MaintenanceNASDAQ:ABVXAbivax SA
26/09/202401:30GlobeNewswire Inc.Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024NASDAQ:ABVXAbivax SA
25/09/202415:01GlobeNewswire Inc.Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse ModelNASDAQ:ABVXAbivax SA
09/09/202415:01GlobeNewswire Inc.Abivax presents first-half 2024 financial resultsNASDAQ:ABVXAbivax SA
09/09/202405:09IH Market NewsU.S. Futures Rise Amid Inflation Report Anticipation; Oil Prices Climb on Hurricane Threat and Supply ConcernsNASDAQ:ABVXAbivax SA
06/08/202401:30GlobeNewswire Inc.Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment MilestoneNASDAQ:ABVXAbivax SA
15/07/202415:00GlobeNewswire Inc.Abivax Provides Operational and Key Program UpdateNASDAQ:ABVXAbivax SA
04/06/202415:10GlobeNewswire Inc.Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General MeetingNASDAQ:ABVXAbivax SA
 Showing the most relevant articles for your search:NASDAQ:ABVX

Su Consulta Reciente

NYSE
VZ
Verizon Communications
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLV
Health Care Select Sector
USI
USTECH100
US Tech 100
AMEX
SPY
SPDR S&P 500
COIN
BTCUSD
Bitcoin
NYSE
MRK
Merck
NASDAQ
MSFT
Microsoft
USOTC
BASFY
BASF (QX)
AMEX
XLF
Financial Select Sector
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
XLE
Energy Select Sector SPDR
COIN
ETHUSD
Ethereum
NYSE
JPM
JP Morgan Chase
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados